← Back to Intel
Insider ActivityURGN
Schoenberg Mark, Chief Medical Officer at UroGen Pharma Ltd., sold $300K of URGN
Updated Jun 12, 2026
Schoenberg Mark
Chief Medical Officer
UroGen Pharma Ltd. ·
$URGN
Transaction Details
| Insider | Schoenberg Mark |
|---|---|
| Title | Chief Medical Officer |
| Company | UroGen Pharma Ltd. |
| Ticker | URGN |
| Transaction Type | Sale |
| Transaction Date | 2026-05-08 |
| Shares Traded | 10,000 |
| Price Per Share | $30 |
| Total Value | $300K |
| Filed Date | 2026-05-11 |
| Accession Number | 0001437749-26-016104 |
Ownership Context
| Shares Owned After Transaction | 134,985 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001437749-26-016104
Other Insider Trades — URGN
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Schoenberg Mark | Chief Medical Officer | traded | — | 2026-06-08 |
| Schoenberg Mark | Chief Medical Officer | sold | $143K | 2026-06-08 |
| Robinson James A. Jr. | Director | traded | — | 2026-05-26 |
Other Trades by Schoenberg Mark
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | traded | — | 2026-06-08 |
| URGN | UroGen Pharma Ltd. | sold | $143K | 2026-06-08 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for URGN — UroGen Pharma Ltd. →
Track URGN insider activity in real time on The Wire →
Get alerts when Schoenberg Mark files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 12, 2026 at 07:08 UTC